Abzena PLC (LON:ABZA)‘s stock had its “buy” rating reissued by equities research analysts at Numis Securities Ltd in a research note issued to investors on Tuesday, July 11th, MarketBeat Ratings reports. They currently have a GBX 93 ($1.21) target price on the stock. Numis Securities Ltd’s price objective would indicate a potential upside of 80.58% from the stock’s current price.
Several other analysts have also recently commented on ABZA. N+1 Singer reiterated a “corporate” rating on shares of Abzena PLC in a report on Thursday, April 6th. FinnCap restated a “buy” rating and set a GBX 80 ($1.04) price target (down from GBX 100 ($1.31)) on shares of Abzena PLC in a report on Friday, April 28th.
Abzena PLC (ABZA) remained flat at GBX 51.50 on Tuesday. 2,500 shares of the stock traded hands. The stock’s market cap is GBX 70.99 million. Abzena PLC has a one year low of GBX 31.00 and a one year high of GBX 66.00. The firm’s 50-day moving average price is GBX 45.80 and its 200-day moving average price is GBX 39.42.
WARNING: This piece of content was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://sportsperspectives.com/2017/07/24/abzena-plcs-abza-buy-rating-reiterated-at-numis-securities-ltd-updated.html.
Abzena PLC Company Profile
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.
Receive News & Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related companies with MarketBeat.com's FREE daily email newsletter.